Abstract
Related Posts
- 1151 Antibody-drug conjugates targeting CLDN18.2 for the treatment of solid tumors
Background CLDN18.2 protein, an isoform of Claudin 18, is a member of the tight junction…
- Anti-CD38 Monoclonal Antibody CM313 in Relapsed/Refractory Multiple Myeloma or Lymphoma Patients
KEY TAKEAWAYS The phase 1 trial of CM313 aimed to assess the safety and preliminary…
- Elotuzumab, an Anti-SLAMF7 Monoclonal Antibody in Patients with Myelofibrosis
KEY TAKEAWAYS The phase 2 study aimed to evaluate the effectiveness and safety of Elotuzumab…